Rice University — sometimes known as the "Ivy League of the South" — has been ranked as the best school in the Lone Star State. Courtesy of Rice University

By any measure, Rice University is a top-tier academic institution, lauded locally and nationally for its innovative tuition programs and for boasting the highest-paid graduates in the state. Now, a new ranking names the "Ivy League of the South" the top university in Texas.

Personal finance website WalletHub has released its 2020's Best College & University Rankings, just in time for the looming November 1 "early decision" college application deadline. Rice takes the No. 1 Texas spot and comes in at No. 13 overall in the U.S.

In order to determine the rankings, WalletHub compared more than 1,000 colleges and universities across seven key dimensions: student selectivity, cost and financing, faculty resources, campus safety, campus experience, educational outcomes, and career outcomes.

Among Texas schools, Rice comes in first for the following individual metrics: admission rate, student-faculty ratio, graduation rate, and post-attendance median salary. The school places second for gender and racial diversity.

The University of Texas at Austin follows as the No. 2 best school in Texas, while Trinity University comes in third. Here are the top 10 schools in Texas, according to WalletHub:

  1. Rice University
  2. University of Texas at Austin
  3. Trinity University
  4. Baylor University
  5. LeTourneau University
  6. Texas Christian University
  7. Texas A&M University-College Station
  8. University of Dallas
  9. Southwestern University
  10. Southern Methodist University

At No. 13 on the overall list, Rice shares the spotlight with prestigious institutions, coming in behind the Massachusetts Institute of Technology, Harvard University, Princeton University, Yale University, Stanford University, the California Institute of Technology, Duke University, University of Pennsylvania, Northwestern University, University of North Carolina — Chapel Hill, Vanderbilt University, and Columbia University. University of Chicago is No. 14.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”